HomeESPR • NASDAQ
add
Esperion Therapeutics Inc
$4.01
Makalipas ang Oras ng Trabaho:(0.50%)-0.020
$3.99
Sarado: Nob 28, 2:36:21 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.95
Sakop ng araw
$3.88 - $4.02
Sakop ng taon
$0.69 - $4.02
Market cap
958.64M USD
Average na Volume
6.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 87.31M | 69.10% |
Gastos sa pagpapatakbo | 41.85M | 4.69% |
Net na kita | -31.33M | -6.13% |
Net profit margin | -35.89 | 37.23% |
Kita sa bawat share | -0.16 | -6.67% |
EBITDA | -9.93M | 37.92% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 92.45M | -36.12% |
Kabuuang asset | 364.02M | 15.89% |
Kabuuang sagutin | 815.38M | 19.15% |
Kabuuang equity | -451.36M | — |
Natitirang share | 237.07M | — |
Presyo para makapag-book | -1.80 | — |
Return on assets | -7.00% | — |
Return on capital | -15.84% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -31.33M | -6.13% |
Cash mula sa mga operasyon | -4.29M | 87.87% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 10.67M | 217.34% |
Net change in cash | 6.39M | 114.32% |
Malayang cash flow | 3.71M | 109.69% |
Tungkol
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Itinatag
May 1998
Website
Mga Empleyado
304
